Liaoning Chengda Biotechnology Co.,Ltd. (SHA:688739)
China
· Delayed Price · Currency is CNY 23.26
-0.57 (-2.39%)
At close: Apr 29, 2026
SHA:688739 Market Cap
SHA:688739 has a market cap or net worth of 9.57 billion as of April 29, 2026. Its market cap has decreased by -13.52% in one year.
Market Cap
9.57B
Enterprise Value
4.36B
Revenue
1.39B
Ranking
n/a
PE Ratio
72.69
Stock Price
23.26
Market Cap Chart
Since October 28, 2021, SHA:688739's market cap has decreased from 33.32B to 9.57B, a decrease of -71.29%. That is a compound annual growth rate of -24.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 9.80B | -7.49% |
| Dec 31, 2025 | 10.59B | -0.17% |
| Dec 31, 2024 | 10.61B | -21.62% |
| Dec 29, 2023 | 13.54B | 6.87% |
| Dec 30, 2022 | 12.67B | -60.04% |
| Dec 31, 2021 | 31.70B | -4.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Hotgen Biotech | 9.75B |
| Aurisco Pharmaceutical | 9.53B |
| Bio-Thera Solutions | 9.29B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 9.28B |
| Shanghai Medicilon | 9.23B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 9.05B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 10.53B |
| HitGen | 10.63B |